Andean Precious Metals (CVE:APM) Stock Price Up 7.5% – Should You Buy?

Andean Precious Metals Corp. (CVE:APMGet Free Report) was up 7.5% during trading on Thursday . The company traded as high as C$1.29 and last traded at C$1.29. Approximately 225,691 shares changed hands during trading, an increase of 41% from the average daily volume of 159,585 shares. The stock had previously closed at C$1.20.

Analysts Set New Price Targets

Separately, Desjardins upgraded shares of Andean Precious Metals to a “moderate buy” rating in a research report on Thursday, October 31st.

Read Our Latest Stock Analysis on Andean Precious Metals

Andean Precious Metals Trading Up 7.5 %

The company has a 50 day moving average of C$1.33 and a 200 day moving average of C$1.26. The firm has a market cap of C$192.67 million, a price-to-earnings ratio of 3.39 and a beta of 1.22.

Insider Activity

In other news, Senior Officer Juan Carlos Sandoval Amare acquired 31,300 shares of the firm’s stock in a transaction that occurred on Friday, January 3rd. The stock was acquired at an average cost of C$1.21 per share, for a total transaction of C$37,860.48. 69.37% of the stock is currently owned by company insiders.

About Andean Precious Metals

(Get Free Report)

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.

Read More

Receive News & Ratings for Andean Precious Metals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andean Precious Metals and related companies with MarketBeat.com's FREE daily email newsletter.